Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-label, Phase 2 Study of Adjuvant Apalutamide or Standard of Care in Subjects With High-risk, Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy

NCT04295447 is registered in ClinicalTrials.gov with Universität Münster as lead sponsor.

NCT NCT04295447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04295447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-label, Phase 2 Study of Adjuvant Apalutamide or Standard of Care in Subjects With High-risk, Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy
Lead sponsor
Universität Münster
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 10, 2020
Completion date
November 30, 2028
Enrollment
190 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasms